Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Current Topics in Medicinal Chemistry|June 30, 2010
Radioligands for the PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5)Linjing Mu, P August Schubiger, Simon M Ametamey
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2006
Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targetingCristina Müller, Alexander Hohn, P August Schubiger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2006
Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivoCristina Müller, Matthias Brühlmeier, P August Schubiger, et al.
The Journal of Biological Chemistry|May 21, 2004
Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domainMonika Heiz, Jürgen Grünberg, P August Schubiger, et al.
Journal of Molecular Modeling|July 9, 2008
Homology modeling and dynamics of the extracellular domain of rat and human neuronal nicotinic acetylcholine receptor subtypes alpha4beta2 and alpha7William H Bisson, Gerrit Westera, P Augustus Schubiger, et al.
Nuclear Medicine and Biology|October 19, 2006
Evaluation of 177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo propertiesKarin Knogler, Jürgen Grünberg, Ilse Novak-Hofer, et al.
Nuclear Medicine and Biology|November 14, 2007
Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5Michael Honer, Anja Stoffel, Lea J Kessler, et al.
Journal of Medicinal Chemistry|August 5, 2005
Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular dockingWilliam H Bisson, Leonardo Scapozza, Gerrit Westera, et al.
Nuclear Medicine and Biology|May 28, 2003
Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imagingKurt Zimmermann, Jürgen Grünberg, Michael Honer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 12, 2008
A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumoursElisa García-Garayoa, Peter Bläuenstein, Alain Blanc, et al.
Pageof 6